Doctor profile · Federal record
Dr. Peter Oppelt, MD
Medical Oncology Physician (CMS: Medical Oncology) · Saint Louis, MO
- NPI 1639332968
- Accepts Medicare
- MIPS 79.3 / 100 · 2023
- 18 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
4921 Parkview Pl, Div Im Medical Oncology, Ste 7A, 7B, 7C
Saint Louis, MO 631101032
(800) 647-2098
fax (314) 362-3192 - Mailing address
-
Po Box 7412011
Chicago, IL 606742011
Credentials & registration
- NPI registered
- July 2008 — 18 yrs on file
- Profile last updated
- April 17, 2025
- Year of graduation
- 2008 — 18 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- Missouri #2015014057
- Medicaid
- MO #200022169
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1639332968. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
174,481
Distinct HCPCS
10
Medicare allowed
$3,197,419
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9271 |
Injection, pembrolizumab, 1 mg | 28,200 | 52 | $54 | |
J9263 |
Injection, oxaliplatin, 0.5 mg | 20,170 | 22 | $0 | |
J1439 |
Injection, ferric carboxymaltose, 1 mg | 16,500 | 19 | $1 | |
J1453 |
Injection, fosaprepitant, 1 mg | 16,200 | 53 | $0 | |
J9299 |
Injection, nivolumab, 1 mg | 9,480 | 15 | $27 | |
J9264 |
Injection, paclitaxel protein-bound particles, 1 mg | 9,300 | 13 | $12 | |
Q5101 |
Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram | 7,200 | 13 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 6,900 | 36 | $23 | |
J0461 |
Injection, atropine sulfate, 0.01 mg | 6,780 | 16 | $0 | |
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 5,970 | 13 | $3 |
In context: peer comparison
Among 44 peers in Saint Louis Medical Oncology Physician, average services per provider: 919. This provider delivers 190× the peer median.Open Payments
Industry payments received
All-time total
$2,240
Transactions
5
Manufacturers
2
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals Lp | 4 | $2,100.00 | |
| Coherus Biosciences INC. | 1 | $140.35 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,255
Patients
458
Total drug cost
$465,962
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Oxycodone Hcl | Generic | 173 | 57 | $4,466 |
| Levothyroxine Sodium | Generic | 172 | 34 | $2,000 |
| Prednisone | Generic | 167 | 57 | $1,169 |
| Prochlorperazine Maleate | Generic | 163 | 103 | $4,767 |
| Ondansetron Hcl | Generic | 139 | 84 | $1,175 |
| Dexamethasone | Generic | 96 | 53 | $1,808 |
| Abiraterone Acetate | Generic | 73 | 13 | $28,689 |
| Gabapentin | Generic | 63 | 18 | $790 |
| Pantoprazole Sodium | Generic | 36 | 0 | $458 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 33 | 14 | $1,639 |
Hospital affiliations
Frequently asked questions
What is Dr. Peter Oppelt's medical specialty?
Dr. Peter Oppelt practices Medical Oncology Physician in Saint Louis, MO.
Where does Dr. Peter Oppelt practice?
Dr. Peter Oppelt practices at 4921 Parkview Pl, Saint Louis, MO 631101032. Office phone: 8006472098.
What is Dr. Peter Oppelt's NPI?
Dr. Peter Oppelt's National Provider Identifier (NPI) is 1639332968, issued by NPPES.
Does Dr. Peter Oppelt accept Medicare assignment?
Yes. Dr. Peter Oppelt accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Peter Oppelt commonly perform?
Top Medicare-reported procedures in 2023: Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, oxaliplatin, 0.5 mg (HCPCS J9263); Injection, ferric carboxymaltose, 1 mg (HCPCS J1439). Source: CMS Medicare Physician & Other Practitioners file.